ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Outsourcing Services (CXO) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-15O16457
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Outsourcing Services CXO Market Research Report 2023
BUY CHAPTERS

Global Pharmaceutical Outsourcing Services (CXO) Market Research Report 2025

Code: QYRE-Auto-15O16457
Report
May 2025
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lonza Pharmaceuticals
Thermo Fisher
Jubilant Lifesciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
IQVIA
Labcorp Drug Development
WuXi AppTec
He Yuan Biology
Genscript Biotech
Kanglong Chemical
Porton shares
Notai Biotech
Jiuzhou Pharmaceutical
Asymchem Laboratories (Tianjin) Co.,Ltd.
Shanghai Medicilon Inc
ChemPartner
AmbioPharm
CordenPharma
Caterent

Pharmaceutical Outsourcing Services (CXO) Market

The global market for Pharmaceutical Outsourcing Services (CXO) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Lonza Pharmaceuticals
Thermo Fisher
Caterent
Jubilant LifeSciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
WuXi AppTec
He Yuan Biology
GenScript Biotech
Kanglong Chemical
Porton shares
Notai Biotech
Jiuzhou Pharmaceutical
Kai Laiying
Medici
CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract production services (CDMOCMO). In the process of new drug R&D, through pharmaceutical contract outsourcing, pharmaceutical companies or biotechnology companies entrust drug R&D and production companies to provide professional R&D services, including the development of technical processes required for the production of drugs, the production of APIs and intermediates, and preparation production.
North American market for Pharmaceutical Outsourcing Services (CXO) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical Outsourcing Services (CXO) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pharmaceutical Outsourcing Services (CXO) in Clinical Stage Projects is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pharmaceutical Outsourcing Services (CXO) include Lonza Pharmaceuticals, Thermo Fisher, Caterent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, IQVIA, Labcorp Drug Development, WuXi AppTec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Outsourcing Services (CXO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Outsourcing Services (CXO).
The Pharmaceutical Outsourcing Services (CXO) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Outsourcing Services (CXO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Outsourcing Services (CXO) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical Outsourcing Services (CXO) Market Report

Report Metric Details
Report Name Pharmaceutical Outsourcing Services (CXO) Market
Segment by Type
  • CRO
  • CMO/CDMO
  • CSO
Segment by Application
  • Clinical Stage Projects
  • Commercialization Stage Projects
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza Pharmaceuticals, Thermo Fisher, Caterent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, IQVIA, Labcorp Drug Development, WuXi AppTec, He Yuan Biology, GenScript Biotech, Kanglong Chemical, Porton shares, Notai Biotech, Jiuzhou Pharmaceutical, Asymchem Laboratories (Tianjin) Co., Ltd., Shanghai Medicilon Inc., ChemPartner, AmbioPharm, CordenPharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical Outsourcing Services (CXO) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical Outsourcing Services (CXO) Market report?

Ans: The main players in the Pharmaceutical Outsourcing Services (CXO) Market are Lonza Pharmaceuticals, Thermo Fisher, Caterent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, IQVIA, Labcorp Drug Development, WuXi AppTec, He Yuan Biology, GenScript Biotech, Kanglong Chemical, Porton shares, Notai Biotech, Jiuzhou Pharmaceutical, Asymchem Laboratories (Tianjin) Co., Ltd., Shanghai Medicilon Inc., ChemPartner, AmbioPharm, CordenPharma

What are the Application segmentation covered in the Pharmaceutical Outsourcing Services (CXO) Market report?

Ans: The Applications covered in the Pharmaceutical Outsourcing Services (CXO) Market report are Clinical Stage Projects, Commercialization Stage Projects

What are the Type segmentation covered in the Pharmaceutical Outsourcing Services (CXO) Market report?

Ans: The Types covered in the Pharmaceutical Outsourcing Services (CXO) Market report are CRO, CMO/CDMO, CSO

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CRO
1.2.3 CMO/CDMO
1.2.4 CSO
1.3 Market by Application
1.3.1 Global Pharmaceutical Outsourcing Services (CXO) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Stage Projects
1.3.3 Commercialization Stage Projects
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Outsourcing Services (CXO) Market Perspective (2020-2031)
2.2 Global Pharmaceutical Outsourcing Services (CXO) Growth Trends by Region
2.2.1 Global Pharmaceutical Outsourcing Services (CXO) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Outsourcing Services (CXO) Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Outsourcing Services (CXO) Market Dynamics
2.3.1 Pharmaceutical Outsourcing Services (CXO) Industry Trends
2.3.2 Pharmaceutical Outsourcing Services (CXO) Market Drivers
2.3.3 Pharmaceutical Outsourcing Services (CXO) Market Challenges
2.3.4 Pharmaceutical Outsourcing Services (CXO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Outsourcing Services (CXO) Players by Revenue
3.1.1 Global Top Pharmaceutical Outsourcing Services (CXO) Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Outsourcing Services (CXO) Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Outsourcing Services (CXO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Outsourcing Services (CXO) Revenue
3.4 Global Pharmaceutical Outsourcing Services (CXO) Market Concentration Ratio
3.4.1 Global Pharmaceutical Outsourcing Services (CXO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Outsourcing Services (CXO) Revenue in 2024
3.5 Global Key Players of Pharmaceutical Outsourcing Services (CXO) Head office and Area Served
3.6 Global Key Players of Pharmaceutical Outsourcing Services (CXO), Product and Application
3.7 Global Key Players of Pharmaceutical Outsourcing Services (CXO), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Outsourcing Services (CXO) Breakdown Data by Type
4.1 Global Pharmaceutical Outsourcing Services (CXO) Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Outsourcing Services (CXO) Breakdown Data by Application
5.1 Global Pharmaceutical Outsourcing Services (CXO) Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Outsourcing Services (CXO) Market Size (2020-2031)
6.2 North America Pharmaceutical Outsourcing Services (CXO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Outsourcing Services (CXO) Market Size (2020-2031)
7.2 Europe Pharmaceutical Outsourcing Services (CXO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Outsourcing Services (CXO) Market Size (2020-2031)
9.2 Latin America Pharmaceutical Outsourcing Services (CXO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza Pharmaceuticals
11.1.1 Lonza Pharmaceuticals Company Details
11.1.2 Lonza Pharmaceuticals Business Overview
11.1.3 Lonza Pharmaceuticals Pharmaceutical Outsourcing Services (CXO) Introduction
11.1.4 Lonza Pharmaceuticals Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.1.5 Lonza Pharmaceuticals Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Pharmaceutical Outsourcing Services (CXO) Introduction
11.2.4 Thermo Fisher Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.2.5 Thermo Fisher Recent Development
11.3 Caterent
11.3.1 Caterent Company Details
11.3.2 Caterent Business Overview
11.3.3 Caterent Pharmaceutical Outsourcing Services (CXO) Introduction
11.3.4 Caterent Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.3.5 Caterent Recent Development
11.4 Jubilant LifeSciences
11.4.1 Jubilant LifeSciences Company Details
11.4.2 Jubilant LifeSciences Business Overview
11.4.3 Jubilant LifeSciences Pharmaceutical Outsourcing Services (CXO) Introduction
11.4.4 Jubilant LifeSciences Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.4.5 Jubilant LifeSciences Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Pharmaceutical Outsourcing Services (CXO) Introduction
11.5.4 Boehringer Ingelheim Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Details
11.6.2 Oxford BioMedica Business Overview
11.6.3 Oxford BioMedica Pharmaceutical Outsourcing Services (CXO) Introduction
11.6.4 Oxford BioMedica Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.6.5 Oxford BioMedica Recent Development
11.7 Charles River
11.7.1 Charles River Company Details
11.7.2 Charles River Business Overview
11.7.3 Charles River Pharmaceutical Outsourcing Services (CXO) Introduction
11.7.4 Charles River Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.7.5 Charles River Recent Development
11.8 IQVIA
11.8.1 IQVIA Company Details
11.8.2 IQVIA Business Overview
11.8.3 IQVIA Pharmaceutical Outsourcing Services (CXO) Introduction
11.8.4 IQVIA Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.8.5 IQVIA Recent Development
11.9 Labcorp Drug Development
11.9.1 Labcorp Drug Development Company Details
11.9.2 Labcorp Drug Development Business Overview
11.9.3 Labcorp Drug Development Pharmaceutical Outsourcing Services (CXO) Introduction
11.9.4 Labcorp Drug Development Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.9.5 Labcorp Drug Development Recent Development
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Details
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec Pharmaceutical Outsourcing Services (CXO) Introduction
11.10.4 WuXi AppTec Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.10.5 WuXi AppTec Recent Development
11.11 He Yuan Biology
11.11.1 He Yuan Biology Company Details
11.11.2 He Yuan Biology Business Overview
11.11.3 He Yuan Biology Pharmaceutical Outsourcing Services (CXO) Introduction
11.11.4 He Yuan Biology Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.11.5 He Yuan Biology Recent Development
11.12 GenScript Biotech
11.12.1 GenScript Biotech Company Details
11.12.2 GenScript Biotech Business Overview
11.12.3 GenScript Biotech Pharmaceutical Outsourcing Services (CXO) Introduction
11.12.4 GenScript Biotech Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.12.5 GenScript Biotech Recent Development
11.13 Kanglong Chemical
11.13.1 Kanglong Chemical Company Details
11.13.2 Kanglong Chemical Business Overview
11.13.3 Kanglong Chemical Pharmaceutical Outsourcing Services (CXO) Introduction
11.13.4 Kanglong Chemical Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.13.5 Kanglong Chemical Recent Development
11.14 Porton shares
11.14.1 Porton shares Company Details
11.14.2 Porton shares Business Overview
11.14.3 Porton shares Pharmaceutical Outsourcing Services (CXO) Introduction
11.14.4 Porton shares Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.14.5 Porton shares Recent Development
11.15 Notai Biotech
11.15.1 Notai Biotech Company Details
11.15.2 Notai Biotech Business Overview
11.15.3 Notai Biotech Pharmaceutical Outsourcing Services (CXO) Introduction
11.15.4 Notai Biotech Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.15.5 Notai Biotech Recent Development
11.16 Jiuzhou Pharmaceutical
11.16.1 Jiuzhou Pharmaceutical Company Details
11.16.2 Jiuzhou Pharmaceutical Business Overview
11.16.3 Jiuzhou Pharmaceutical Pharmaceutical Outsourcing Services (CXO) Introduction
11.16.4 Jiuzhou Pharmaceutical Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.16.5 Jiuzhou Pharmaceutical Recent Development
11.17 Asymchem Laboratories (Tianjin) Co., Ltd.
11.17.1 Asymchem Laboratories (Tianjin) Co., Ltd. Company Details
11.17.2 Asymchem Laboratories (Tianjin) Co., Ltd. Business Overview
11.17.3 Asymchem Laboratories (Tianjin) Co., Ltd. Pharmaceutical Outsourcing Services (CXO) Introduction
11.17.4 Asymchem Laboratories (Tianjin) Co., Ltd. Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.17.5 Asymchem Laboratories (Tianjin) Co., Ltd. Recent Development
11.18 Shanghai Medicilon Inc.
11.18.1 Shanghai Medicilon Inc. Company Details
11.18.2 Shanghai Medicilon Inc. Business Overview
11.18.3 Shanghai Medicilon Inc. Pharmaceutical Outsourcing Services (CXO) Introduction
11.18.4 Shanghai Medicilon Inc. Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.18.5 Shanghai Medicilon Inc. Recent Development
11.19 ChemPartner
11.19.1 ChemPartner Company Details
11.19.2 ChemPartner Business Overview
11.19.3 ChemPartner Pharmaceutical Outsourcing Services (CXO) Introduction
11.19.4 ChemPartner Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.19.5 ChemPartner Recent Development
11.20 AmbioPharm
11.20.1 AmbioPharm Company Details
11.20.2 AmbioPharm Business Overview
11.20.3 AmbioPharm Pharmaceutical Outsourcing Services (CXO) Introduction
11.20.4 AmbioPharm Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.20.5 AmbioPharm Recent Development
11.21 CordenPharma
11.21.1 CordenPharma Company Details
11.21.2 CordenPharma Business Overview
11.21.3 CordenPharma Pharmaceutical Outsourcing Services (CXO) Introduction
11.21.4 CordenPharma Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.21.5 CordenPharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Lonza Pharmaceuticals
Thermo Fisher
Jubilant Lifesciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
IQVIA
Labcorp Drug Development
WuXi AppTec
He Yuan Biology
Genscript Biotech
Kanglong Chemical
Porton shares
Notai Biotech
Jiuzhou Pharmaceutical
Asymchem Laboratories (Tianjin) Co.,Ltd.
Shanghai Medicilon Inc
ChemPartner
AmbioPharm
CordenPharma
Caterent
List of Tables
 Table 1. Global Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of CRO
 Table 3. Key Players of CMO/CDMO
 Table 4. Key Players of CSO
 Table 5. Global Pharmaceutical Outsourcing Services (CXO) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmaceutical Outsourcing Services (CXO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pharmaceutical Outsourcing Services (CXO) Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Region (2020-2025)
 Table 9. Global Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Region (2026-2031)
 Table 11. Pharmaceutical Outsourcing Services (CXO) Market Trends
 Table 12. Pharmaceutical Outsourcing Services (CXO) Market Drivers
 Table 13. Pharmaceutical Outsourcing Services (CXO) Market Challenges
 Table 14. Pharmaceutical Outsourcing Services (CXO) Market Restraints
 Table 15. Global Pharmaceutical Outsourcing Services (CXO) Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Players (2020-2025)
 Table 17. Global Top Pharmaceutical Outsourcing Services (CXO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Outsourcing Services (CXO) as of 2024)
 Table 18. Ranking of Global Top Pharmaceutical Outsourcing Services (CXO) Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Pharmaceutical Outsourcing Services (CXO) Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Pharmaceutical Outsourcing Services (CXO), Headquarters and Area Served
 Table 21. Global Key Players of Pharmaceutical Outsourcing Services (CXO), Product and Application
 Table 22. Global Key Players of Pharmaceutical Outsourcing Services (CXO), Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Pharmaceutical Outsourcing Services (CXO) Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Pharmaceutical Outsourcing Services (CXO) Revenue Market Share by Type (2020-2025)
 Table 26. Global Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Pharmaceutical Outsourcing Services (CXO) Revenue Market Share by Type (2026-2031)
 Table 28. Global Pharmaceutical Outsourcing Services (CXO) Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Pharmaceutical Outsourcing Services (CXO) Revenue Market Share by Application (2020-2025)
 Table 30. Global Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Pharmaceutical Outsourcing Services (CXO) Revenue Market Share by Application (2026-2031)
 Table 32. North America Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Lonza Pharmaceuticals Company Details
 Table 48. Lonza Pharmaceuticals Business Overview
 Table 49. Lonza Pharmaceuticals Pharmaceutical Outsourcing Services (CXO) Product
 Table 50. Lonza Pharmaceuticals Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 51. Lonza Pharmaceuticals Recent Development
 Table 52. Thermo Fisher Company Details
 Table 53. Thermo Fisher Business Overview
 Table 54. Thermo Fisher Pharmaceutical Outsourcing Services (CXO) Product
 Table 55. Thermo Fisher Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 56. Thermo Fisher Recent Development
 Table 57. Caterent Company Details
 Table 58. Caterent Business Overview
 Table 59. Caterent Pharmaceutical Outsourcing Services (CXO) Product
 Table 60. Caterent Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 61. Caterent Recent Development
 Table 62. Jubilant LifeSciences Company Details
 Table 63. Jubilant LifeSciences Business Overview
 Table 64. Jubilant LifeSciences Pharmaceutical Outsourcing Services (CXO) Product
 Table 65. Jubilant LifeSciences Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 66. Jubilant LifeSciences Recent Development
 Table 67. Boehringer Ingelheim Company Details
 Table 68. Boehringer Ingelheim Business Overview
 Table 69. Boehringer Ingelheim Pharmaceutical Outsourcing Services (CXO) Product
 Table 70. Boehringer Ingelheim Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 71. Boehringer Ingelheim Recent Development
 Table 72. Oxford BioMedica Company Details
 Table 73. Oxford BioMedica Business Overview
 Table 74. Oxford BioMedica Pharmaceutical Outsourcing Services (CXO) Product
 Table 75. Oxford BioMedica Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 76. Oxford BioMedica Recent Development
 Table 77. Charles River Company Details
 Table 78. Charles River Business Overview
 Table 79. Charles River Pharmaceutical Outsourcing Services (CXO) Product
 Table 80. Charles River Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 81. Charles River Recent Development
 Table 82. IQVIA Company Details
 Table 83. IQVIA Business Overview
 Table 84. IQVIA Pharmaceutical Outsourcing Services (CXO) Product
 Table 85. IQVIA Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 86. IQVIA Recent Development
 Table 87. Labcorp Drug Development Company Details
 Table 88. Labcorp Drug Development Business Overview
 Table 89. Labcorp Drug Development Pharmaceutical Outsourcing Services (CXO) Product
 Table 90. Labcorp Drug Development Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 91. Labcorp Drug Development Recent Development
 Table 92. WuXi AppTec Company Details
 Table 93. WuXi AppTec Business Overview
 Table 94. WuXi AppTec Pharmaceutical Outsourcing Services (CXO) Product
 Table 95. WuXi AppTec Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 96. WuXi AppTec Recent Development
 Table 97. He Yuan Biology Company Details
 Table 98. He Yuan Biology Business Overview
 Table 99. He Yuan Biology Pharmaceutical Outsourcing Services (CXO) Product
 Table 100. He Yuan Biology Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 101. He Yuan Biology Recent Development
 Table 102. GenScript Biotech Company Details
 Table 103. GenScript Biotech Business Overview
 Table 104. GenScript Biotech Pharmaceutical Outsourcing Services (CXO) Product
 Table 105. GenScript Biotech Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 106. GenScript Biotech Recent Development
 Table 107. Kanglong Chemical Company Details
 Table 108. Kanglong Chemical Business Overview
 Table 109. Kanglong Chemical Pharmaceutical Outsourcing Services (CXO) Product
 Table 110. Kanglong Chemical Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 111. Kanglong Chemical Recent Development
 Table 112. Porton shares Company Details
 Table 113. Porton shares Business Overview
 Table 114. Porton shares Pharmaceutical Outsourcing Services (CXO) Product
 Table 115. Porton shares Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 116. Porton shares Recent Development
 Table 117. Notai Biotech Company Details
 Table 118. Notai Biotech Business Overview
 Table 119. Notai Biotech Pharmaceutical Outsourcing Services (CXO) Product
 Table 120. Notai Biotech Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 121. Notai Biotech Recent Development
 Table 122. Jiuzhou Pharmaceutical Company Details
 Table 123. Jiuzhou Pharmaceutical Business Overview
 Table 124. Jiuzhou Pharmaceutical Pharmaceutical Outsourcing Services (CXO) Product
 Table 125. Jiuzhou Pharmaceutical Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 126. Jiuzhou Pharmaceutical Recent Development
 Table 127. Asymchem Laboratories (Tianjin) Co., Ltd. Company Details
 Table 128. Asymchem Laboratories (Tianjin) Co., Ltd. Business Overview
 Table 129. Asymchem Laboratories (Tianjin) Co., Ltd. Pharmaceutical Outsourcing Services (CXO) Product
 Table 130. Asymchem Laboratories (Tianjin) Co., Ltd. Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 131. Asymchem Laboratories (Tianjin) Co., Ltd. Recent Development
 Table 132. Shanghai Medicilon Inc. Company Details
 Table 133. Shanghai Medicilon Inc. Business Overview
 Table 134. Shanghai Medicilon Inc. Pharmaceutical Outsourcing Services (CXO) Product
 Table 135. Shanghai Medicilon Inc. Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 136. Shanghai Medicilon Inc. Recent Development
 Table 137. ChemPartner Company Details
 Table 138. ChemPartner Business Overview
 Table 139. ChemPartner Pharmaceutical Outsourcing Services (CXO) Product
 Table 140. ChemPartner Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 141. ChemPartner Recent Development
 Table 142. AmbioPharm Company Details
 Table 143. AmbioPharm Business Overview
 Table 144. AmbioPharm Pharmaceutical Outsourcing Services (CXO) Product
 Table 145. AmbioPharm Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 146. AmbioPharm Recent Development
 Table 147. CordenPharma Company Details
 Table 148. CordenPharma Business Overview
 Table 149. CordenPharma Pharmaceutical Outsourcing Services (CXO) Product
 Table 150. CordenPharma Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
 Table 151. CordenPharma Recent Development
 Table 152. Research Programs/Design for This Report
 Table 153. Key Data Information from Secondary Sources
 Table 154. Key Data Information from Primary Sources
 Table 155. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical Outsourcing Services (CXO) Picture
 Figure 2. Global Pharmaceutical Outsourcing Services (CXO) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Type: 2024 VS 2031
 Figure 4. CRO Features
 Figure 5. CMO/CDMO Features
 Figure 6. CSO Features
 Figure 7. Global Pharmaceutical Outsourcing Services (CXO) Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Application: 2024 VS 2031
 Figure 9. Clinical Stage Projects Case Studies
 Figure 10. Commercialization Stage Projects Case Studies
 Figure 11. Pharmaceutical Outsourcing Services (CXO) Report Years Considered
 Figure 12. Global Pharmaceutical Outsourcing Services (CXO) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Pharmaceutical Outsourcing Services (CXO) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Region: 2024 VS 2031
 Figure 15. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Players in 2024
 Figure 16. Global Top Pharmaceutical Outsourcing Services (CXO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Outsourcing Services (CXO) as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Outsourcing Services (CXO) Revenue in 2024
 Figure 18. North America Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Pharmaceutical Outsourcing Services (CXO) Market Share by Country (2020-2031)
 Figure 20. United States Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pharmaceutical Outsourcing Services (CXO) Market Share by Country (2020-2031)
 Figure 24. Germany Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Share by Region (2020-2031)
 Figure 32. China Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pharmaceutical Outsourcing Services (CXO) Market Share by Country (2020-2031)
 Figure 40. Mexico Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Share by Country (2020-2031)
 Figure 44. Turkey Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Lonza Pharmaceuticals Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 48. Thermo Fisher Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 49. Caterent Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 50. Jubilant LifeSciences Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 51. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 52. Oxford BioMedica Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 53. Charles River Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 54. IQVIA Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 55. Labcorp Drug Development Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 56. WuXi AppTec Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 57. He Yuan Biology Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 58. GenScript Biotech Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 59. Kanglong Chemical Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 60. Porton shares Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 61. Notai Biotech Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 62. Jiuzhou Pharmaceutical Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 63. Asymchem Laboratories (Tianjin) Co., Ltd. Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 64. Shanghai Medicilon Inc. Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 65. ChemPartner Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 66. AmbioPharm Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 67. CordenPharma Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions